Sage Journals: Discover world-class research

Abstract

Background:

There is limited and inconsistent information on the clinical determinants of cognitive impairment (CI) in multiple sclerosis (MS).

Objective:

The aim of this study was to compare the prevalence and profile of CI across MS disease subtypes and assess its clinical determinants.

Methods:

Cognitive performance was assessed through the Brief Repeatable Battery and the Stroop test in consecutive patients with MS referred to six Italian centers. CI was defined as impairment in ⩾ 2 cognitive domains.

Results:

A total of 1040 patients were included, 167 with clinically isolated syndrome (CIS), 759 with relapsing remitting (RR), 74 with secondary progressive (SP), and 40 with primary progressive (PP) disease course. The overall prevalence of CI was 46.3%; 34.5% in CIS, 44.5% in RR, 79.4% in SP, and 91.3% in PP. The severity of impairment and the number of involved domains were significantly higher in SP and primary progressive multiple sclerosis (PPMS) than in CIS and RR. In multivariable logistic regression analysis, the presence of CI was significantly associated with higher Expanded Disability Status Scale (EDSS) and older age.

Conclusion:

CI is present in all MS subtypes since the clinical onset and its frequency is increased in the progressive forms, but these differences seem to be more associated with patient age and physical disability than to disease subtype per se.

Keywords

Multiple sclerosis cognitive impairment disease course epidemiology

Get full access to this article

View all access options for this article.

References

Amato

Zipoli

Portaccio

. Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245: 41–46.

Chiaravalloti

DeLuca

. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139–1151.

Bever

Jr Grattan

Panitch

. The brief repeatable battery of neuropsychological tests for multiple sclerosis: A preliminary serial study. Mult Scler 1995; 1: 165–169.

Langdon

Amato

Boringa

. Recommendaations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18: 891–898.

Huijbregts

Kalkers

de Sonneville

. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 63: 335–339.

Ruet

Deloire

Charre-Morin

. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 2013; 80: 1501–1508.

Planche

Gibelin

Cregut

. Cognitive impairment in a population-based study of patients with multiple sclerosis: Differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur J Neurol 2016; 23: 282–289.

Potagas

Giogkaraki

Koutsis

. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008; 267: 100–106.

Zipoli

Goretti

Hakiki

. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler 2010; 16: 62–67.

10.

Lynch

Parmenter

Denney

. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler 2005; 11: 469–476.

11.

Fischer

Foley

Aikens

. What do we really know about cognitive dysfunction, affective disorders, and stress in multiple sclerosis? A practitioner’s guide. Neurorehab Neural Re 1994; 8: 151–164.

12.

Martins Da Silva

Cavaco

Moreira

. Cognitive reserve in multiple sclerosis: Protective effects of education. Mult Scler 2015; 21: 1312–1321.

13.

Borghi

Cavallo

Carletto

. Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. PLoS ONE 2013; 8: e69820.

14.

McDonald

Compston

Edan

. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

15.

Lublin

Reingold

. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907–911.

16.

Kurtzke

. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

17.

Meyer-Moock

Feng

Maeurer

. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol 2014; 14: 58.

18.

Krupp

LaRocca

Muir-Nash

. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.

19.

Montgomery

Asberg

. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389.

20.

Stroop

. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643–662.

21.

Amato

Portaccio

Goretti

. The Rao’s Brief Repeatable Battery and Stroop Test: Normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787–793.

22.

Stine

. Graphical interpretation of variance inflation factors. Am Stat 1995; 49: 53–56.

23.

Achiron

Chapman

Magalashvili

. Modeling of cognitive impairment by disease duration in multiple sclerosis: A cross-sectional study. PLoS ONE 2013; 8: e71058.

24.

Moccia

Lanzillo

Palladino

. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Multi Scler 2016; 22: 659–667.

25.

Amato

Ponziani

Siracusa

. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol 2001; 58: 1602–1606.

26.

Rocca

Amato

De Stefano

. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 2015; 14: 302–317.

27.

Pardini

Uccelli

Grafman

. Isolated cognitive relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 85: 1035–1037.

28.

Confavreux

Vukusic

. Natural history of multiple sclerosis: A unifying concept. Brain 2006; 129: 606–616.

29.

Cossburn

Ingram

Hirst

. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multi Scler 2012; 18: 45–54.

30.

Schoonheim

Geurts

Barkhof

. The limits of functional reorganization in multiple sclerosis. Neurology 2010; 74: 1246–1247.

31.

Shirani

Zhao

Kingwell

. Temporal trends of disability progression in multiple sclerosis: Findings from British Columbia, Canada (1975–2009). Mult Scler 2012; 18: 442–450.

32.

Savettieri

Messina

Andreoli

. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 2004; 251: 1208–1214.

33.

Aviv

Francis

Tenenbein

. Decreased frontal lobe gray matter perfusion in cognitively impaired patients with secondary-progressive multiple sclerosis detected by the bookend technique. AJNR Am J Neuroradiol 2012; 33: 1779–1785.

34.

Riccitelli

Rocca

Pagani

. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum Brain Mapp 2011; 32: 1535–1543.

35.

Amato

Razzolini

Goretti

. Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study. Neurology 2013; 80: 1728–1733.

36.

Penner

Stemper

Calabrese

. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Multi Scler 2012; 18: 1466–1471.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes

Abstract

Background:

Objective:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material